Cystic Fibrosis: A Paradigm Treatment Shift is Underway
Columbia University pulmonologists conducts clinical trial on novel triple combination modulator for cystic fibrosis in patients with advanced lung disease, demonstrating progressive improvement in weight, lung function, and patient-reported outcomes.
Multipronged Management of Interstitial Lung Disease
Pulmonologists at NewYork-Presbyterian/Weill Cornell Medical Center are developing a new paradigm to confront idiopathic pulmonary fibrosis (IPF) and other forms of progressive fibrotic ILDs.
Investigating the Genetic Connections to Inherited Lung Disease
Dr. Garcia’s research utilizes next generation sequencing and bioinformatic analyses to identify rare mutations in genes linked to inherited forms of lung disease.
The Road Back: Helping Patients Recover Post-ICU
To assist intensive care unit survivors in their recuperation, the Division of Pulmonary and Critical Care Medicine at NewYork-Presbyterian/Weill Cornell Medical Center established a Post-ICU Recovery Clinic.
Dr. Christine Garcia Named Chief of Pulmonary, Allergy, and Critical Care at Columbia
Christine Kim Garcia, MD, PhD, joined NewYork-Presbyterian/Columbia University Irving Medical Center as Associate Chief of the Division of Pulmonary, Allergy, and Critical Care Medicine in January 2019.